BaseClear has years of experience in microbiome analysis, including the analysis of interactions between drugs and the microbiota in clinical trials. The microbiota plays an important role in the efficacy, effectiveness and safety of many drugs, probiotics, cosmetics and other biological compounds. The microbiota influences the bioavailability, toxicity and responsiveness of a patient to a given drug. In opposite, the profile of a patient’s microbiome can predict how the patient responds to a drug.
We routinely organise expert meetings wherein scientists and researchers meet, share and discuss microbiome projects, challenges and opportunities. On Thursday September 5th, we are once again organising an 1-day expert-meeting titled:
The registration for our experts meeting on microbiome analysis for clinical trials is closed. If you have any questions about microbiome-based clinical research or future event, don’t hesitate to contact us.
With her passion for health and wellbeing, Radhika enjoys contributing to sustainability, and to the development of products that will benefit the end user and improve their quality of living. To this end, Radhika heads the commercial activities at BaseClear. “My diverse industry experience helps me envisage out-of-the-box solutions for our customers and to enter to new markets as a company” says Radhika. “It’s crucial that I can identify our customer needs and market trends to steer product development at BaseClear.”
Contact Radhika